Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial (August, 10.1038/s41591-021-01455-x, 2021) Article

Full Text via DOI: 10.1038/s41591-022-02076-8 Web of Science: 000869357500003

Cited authors

  • Dam T, Boxer AL, Golbe LI, Hoglinger GU, Morris HR, Litvan I, Lang ANE, Corvol JC, Aiba I, Grundman M, Yang LL, Tidemann-Miller B, Kupferman J, Harper K, Kamisoglu K, Wald MJ, Graham DL, Gedney L, O'Gorman J, Haeberlein SB, Aiba I, Antonini A, Apetauerova D, Azulay JP, Martinez EB, Bang J, Barone P, Barrett M, Bega D, Berg D, Corrales KB, Bordelon Y, Boxer AL, Brandt M, Brueggemann N, Castelnovo G, Ceravolo R, Chuang RD, Chung SJ, Church A, Corvol JC, Cudia P, Dale M, Defebvre L, Drapier S, Driver-Dunckley ED, Ebersbach G, Eggert KM, Ellenbogen A, Eusebio A, Evans AH, Fedorova N, Finger E, Foubert-Samier A, Ghosh B, Golbe L, Perez FG, Grossman M, Hall D, Hamada K, Hasegawa K, Hoeglinger G, Honig L, Houghton D, Huang XM, Isaacson S, Koh S, Bojarski JK, Lang ANE, Leigh PN, Litvan I, Lozano JJL, Moreno JLLS, Ludolph AC, Piudo MRL, Torres IM, McFarland N, Meissner W, Mestre T, Rivera PM, Molho E, Mollenhauer B, Morris HR, Murata M, Obi T, Magne FO, O'Suilleabhain P, Pahwa R, Pantelyat A, Pavese N, Pokhabov D, Prudlo J, Rodriguez-Porcel F, Rowe J, Savitt J, Schnitzler A, Schulz JB, Seppi K, Shah BI, Shill H, Shprecher D, Stamelou M, Steiger M, Takahashi Y, Takigawa H, Tartaglia C, Toenges L, Truong D, Tse W, Tuite P, Volc D, Wills AMA, Woitalla D, Xie T, Yuasa T, Zauber SE, Zesiewicz T

Publication date

  • 2022

Published in

International Standard Serial Number (ISSN)

  • 1078-8956

Number of pages

  • 2